Difference between revisions of "Lundbeck"

From Powerbase
Jump to: navigation, search
(Lobbying firms)
 
(One intermediate revision by one other user not shown)
Line 23: Line 23:
 
===2014===
 
===2014===
 
*[[Burson-Marsteller]]
 
*[[Burson-Marsteller]]
 +
*[[MHP Communications]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=MHP%20Communications Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 23 February 2015 </ref>
  
 
==Drugs==
 
==Drugs==
 
[[Nalmefene]]
 
[[Nalmefene]]
 +
 +
==Affiliations==
 +
Lundbeck pays the charity [[Alcohol Concern]] an annual grant to act as secretariat to the Westminster-based [[All-Party Parliamentary Group on Alcohol Harm]].
  
 
==Contact==
 
==Contact==

Latest revision as of 10:51, 12 November 2015

H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia.[1]

People

Executive management

Board of Directors

Lobbying firms

2014

Drugs

Nalmefene

Affiliations

Lundbeck pays the charity Alcohol Concern an annual grant to act as secretariat to the Westminster-based All-Party Parliamentary Group on Alcohol Harm.

Contact

H. Lundbeck A/S
Ottiliavej 9 2500 Valby Denmark
Phone +45 3630 1311
Fax: +45 3630 1940
www.lundbeck.com

Notes

  1. About Us, Lundbeck.com.
  2. Agency Register September to November 2014 PRCA, accessed 27 January 2015
  3. Register 1st September 2014 - 30th November 2014 APPC, accessed 23 February 2015